|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector. |
| 公司地址
| 21925 West Field Parkway, Suite 235, Deer Park, IL, USA, 60010-7278 |
| 電話號碼
| +1 847 787-7361 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.etonpharma.com |
| 員工數量
| 44 |
| Mr. Sean E. Brynjelsen |
President, Chief Executive Officer and Director |
美元 712.43K |
24/04/2026 |
| Mr. David C. Krempa |
Chief Business Officer |
美元 460.46K |
24/04/2026 |
| Ms. Ipek Erdogan-Trinkaus |
Chief Commercial Officer |
美元 402.72K |
24/04/2026 |
| Ms. Judith Matthews |
Chief Financial Officer, Treasurer and Secretary |
-- |
16/04/2026 |
|
|
| Mr. Charles J. Casamento |
Independent Director |
24/04/2026 |
| Dr. Norbert G. Riedel,PhD |
Chairman of the Board |
24/04/2026 |
| Mr. Paul Victor Maier |
Independent Director |
24/04/2026 |
| Mr. Sean E. Brynjelsen |
President, Chief Executive Officer and Director |
24/04/2026 |
| Ms. Jennifer McKie Adams |
Independent Director |
24/04/2026 |
|
|
|
|
